Earth Science Tech Inc (OTCMKTS:ETST) reported the plunge of -14.36% and closed at $1.61, with the total traded volume of 89,367.00 shares. During last trade its minimum price was $1.55 and it gained its highest price of $1.88 and has a total of 40.91 million outstanding shares.

On March 14, 2017 Earth Science Tech, Inc. (ETST), an innovative biotech company focused on cannabis (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices is proud to announce its subsidiaries Cannabis Therapeutic, Inc. and Earth Science Pharmaceutical, Inc. the nomination of Kim Foster-Cunningham to the post of Project Manager for the MSN-2 medical device project; and Denis Babin of SDB Import/Export, Inc. as international marketing consultant for Cannabis Therapeutics and Earth Science Pharmaceutical products.

Ms. Foster-Cunningham’s immediate focus is preparatory phase of the pre-market clinical trial of the MSN-2 medical device. The MSN-2 device is a revolutionary medical instrument for the detection and diagnosis of Chlamydia and Gonorrhea, from previous announcement, (ETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.)

Ms. Foster-Cunningham, whom holds a degree in sales and marketing, is recognized for her expertise in business networking and her solid business expertise. She is a sought-after speaker throughout the USA and Canada, delivering conferences on her proactive approach to general health and self-care. Passionate about individual sports, she is a half marathon runner and a triathlete. Always enthusiastic about transmitting her passion for health and business development, this project is “her new baby”.

“I love my work, especially when it allows me to bring my passion for health and business development together, and to bring them to other people,’ says Foster-Cunningham. “This project is my new baby, and I’m excited about the prospects of helping it grow to maturity.”

Medical Marijuana Inc (OTCMKTS:MJNA) showing jumped of 0.41% and closed at $0.123, after gaining total volume of 5.12M shares. Its earnings per share (EPS) is $0.01 and its beta value stands at -1.78 points and has total market capitalization of $371.87 million and a total of 3.03 billion outstanding shares.

Medical Marijuana Inc (MJNA) on March 16, 2017 announced that its subsidiary, Kannaway LLC the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products is holding an exclusive Red-Carpet Event in Denver, CO., this weekend. The Red-Carpet Event provides a unique opportunity to network with top Kannaway leaders, the company’s executive team and fellow business owners.

Attendees will hear from executive team members, including Kannaway CEO Blake Schroeder, President Brad Tayles and CEO of Kannaway parent company Medical Marijuana, Inc., Dr. Stuart Titus. Additionally, the Red-Carpet Event will provide Kannaway business owners with exclusive opportunities to accelerate their success as brand ambassadors, by hearing from some of our top leaders and income earners.

“We are once again excited to host another one of our Kannaway Red-Carpet Events in Denver, providing a chance for to come together and learn more about the Kannaway system and immense possibilities given by being part of the Kannaway business,” Kannaway CEO Blake Schroeder said. “We welcome you to join us as we continue to promote our new messages and brands as well as roll-out new and newly revamped products to our CBD hemp oil lifestyle line.”

The Denver Red-Carpet Event is scheduled from 1-4pm on Saturday, March 18, at the Embassy Suites Denver Southeast. Advance tickets are available now for just $30, the price of tickets will increase to $40 at the door.

Prior to the Red-Carpet Event, Kannaway will host a Business Opportunity Meeting. This meeting will run from 11:30am-12:30pm the day of the show. There is no charge for this portion of the event, and interested prospects who attend can choose to buy a ticket to the ensuing Red-Carpet Event.

MassRoots Inc (OTCMKTS:MSRT) increased 5.26% closed at $0.900 and traded with total volume of 288,741.00 shares, while the average trading remained 606,332.00 shares. During last trade its minimum price was $0.85 and it gained the highest price of $0.90. Its market capitalization was $61.11 million.

MassRoots Inc (MSRT) on March 20, 2017 announced that the company has registered more than one million users on its platform. Through its mobile application, MassRoots enables consumers to rate products and strains based on their efficacy (i.e., working well for back-pain or epilepsy) and then presents this information in easy-to-use formats for consumers to make educated purchasing decisions at their local dispensary.

“MassRoots registering one million users is a significant milestone made possible by the strong support of our shareholders, tireless work of the MassRoots team, and passion of cannabis consumers worldwide,” stated MassRoots Chairman and CEO, Mr. Isaac Dietrich. “In the coming days, we’ll be releasing a revamped website and updates to our mobile application that will significantly enhance our user experience and can be immediately deployed to our vast user base. With the 4/20 holiday season rapidly approaching, we’re preparing for a surge of web traffic, media coverage and user registrations that MassRoots has historically experienced this time of year. We look forward to continuing to expand our market share of cannabis consumers and dispensaries to further drive shareholder value.”